QuickView for response to cisplatin (biogroup)

1. L1000 CMAP - Skeletal muscle SKL.C cells treated with small molecule perturbagens
2. L1000 CMAP - Bone marrow CD34 cells treated with small molecule perturbagens
3. L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
4. L1000 CMAP - Neuronal NEU cells treated with small molecule perturbagens
5. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)

There were no matches for response to cisplatin

1. Genetic Determinants of Response to Neoadjuvant Cisplatin-based Chemotherapy in Urothelial Cancer
2. Genetic Variates of Response to Cisplatin, Vinblastine, and Temozolomide (CVT) in Patients With Meta…
3. 3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetux…
4. Trial Of Cisplatin And KML-001 in Platinum Responsive Malignancies
5. Neoadjuvant Toripalimab and Paclitaxel/Cisplatin on Pathological Response in Oral Squamous Cell Carc…